Thursday, April 3, 2025 4/3/2025

Hypothalamic oxytocin neuron activation rescues cardiac metabolism through cardiac cholinergic signaling in type 2 diabetes

Award Number: F31HL174131
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

Group Awards By:

View Award Description

Hypothalamic oxytocin neuron activation rescues cardiac metabolism through cardiac cholinergic signaling in type 2 diabetes - PROJECT SUMMARY Cardiac autonomic neuropathy (CAN) is a serious complication of type 2 diabetes (T2D) that is strongly associated with approximately five-fold increased risk of cardiovascular mortality. CAN manifests as a decline in parasympathetic tone and overactivation of sympathetic activity that contributes to resting tachycardia and fixed heart rate, and myocardial infarction. Although it is a common complication, very little is known regarding how CAN directly increases the risk for myocardial injury and disease, and thus there are no current unified treatment algorithms other than lifestyle changes, glycemic control and management of cardiovascular risk factors. We have recently identified a novel mechanism for restoring cardioprotective parasympathetic tone to the heart to reduce myocardial damage in diseases with similar autonomic dysfunction, such as heart failure, myocardial infarct, and sleep apnea. Brainstem parasympathetic cardiac vagal neurons (CVNs) receive powerful excitation from a population of oxytocin (OXT) neurons that originate in the paraventricular nucleus of the hypothalamus (PVN). These unique neurons co-release OXT and enhance excitatory glutamatergic neuro-transmission to CVNs. Based upon our novel results in diseases with similar autonomic imbalances, our overall hypothesis is that PVN OXT neuron activation is cardioprotective in type 2 diabetes. This overarching hypothesis will be tested in two Specific Aims. Aim 1 will determine if PVN OXT neuron activation improves cardiac metabolic flexibility by increasing glucose oxidation. Animals will be injected intravenously with heavy-carbon-labelled glucose or palmitate to measure substrate utilization by the heart. Carbon tracing of metabolites in left ventricular samples will reveal changes to energy utilization caused by treatment. Mass-spectrometry will be used to identify the metabolites to test the hypothesis that OXT neuron activation improves cardiac energy metabolism as a mechanism of protection. Aim 2 will determine if PVN OXT neuron activation improves cardiomyocyte calcium cycling and contractility. We will test our hypothesis that PVN OXT neuron activation confers cardioprotection by improving calcium homeostasis and contractility in cardiomyocytes. Using collagenase digestion of hearts from Control, T2D, and Treatment animals we will use assess contractility and calcium flux of individual cardiomyocytes with IonOptix. We will probe for changes to calcium handling protein expression using western blot.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $43,339 )
2025	2025	UNIVERSITY OF HAWAII	2425 CAMPUS RD SINCLAIR RM 1	HONOLULU	HI	96822	HONOLULU	USA	Cardiovascular Diseases Research	000	1	12/6/2024	NEW	$43,339
														Subtotal = $43,339

Grand Total All Awards = $43,339

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Hypothalamic oxytocin neuron activation rescues cardiac metabolism through cardiac cholinergic signaling in type 2 diabetes

Award Number: F31HL174131

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer